<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T09:12:53Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:8138111" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:8138111</identifier>
        <datestamp>2021-05-21</datestamp>
        <setSpec>bmcid</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" article-type="research-article">
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">BMC Infect Dis</journal-id>
              <journal-id journal-id-type="iso-abbrev">BMC Infect Dis</journal-id>
              <journal-title-group>
                <journal-title>BMC Infectious Diseases</journal-title>
              </journal-title-group>
              <issn pub-type="epub">1471-2334</issn>
              <publisher>
                <publisher-name>BioMed Central</publisher-name>
                <publisher-loc>London</publisher-loc>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC8138111</article-id>
              <article-id pub-id-type="pmcid">PMC8138111</article-id>
              <article-id pub-id-type="pmc-uid">8138111</article-id>
              <article-id pub-id-type="pmid">34020607</article-id>
              <article-id pub-id-type="publisher-id">6173</article-id>
              <article-id pub-id-type="doi">10.1186/s12879-021-06173-w</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Technical Advance</subject>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>An <italic>emm</italic>-type specific qPCR to track bacterial load during experimental human <italic>Streptococcus pyogenes</italic> pharyngitis</article-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author" equal-contrib="yes">
                  <name>
                    <surname>Fabri</surname>
                    <given-names>Loraine V.</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                  <xref ref-type="aff" rid="Aff2">2</xref>
                </contrib>
                <contrib contrib-type="author" equal-contrib="yes">
                  <name>
                    <surname>Azzopardi</surname>
                    <given-names>Kristy I.</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                </contrib>
                <contrib contrib-type="author" corresp="yes">
                  <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-9432-6700</contrib-id>
                  <name>
                    <surname>Osowicki</surname>
                    <given-names>Joshua</given-names>
                  </name>
                  <address>
                    <email>joshua.osowicki@rch.org.au</email>
                  </address>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                  <xref ref-type="aff" rid="Aff3">3</xref>
                  <xref ref-type="aff" rid="Aff4">4</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Frost</surname>
                    <given-names>Hannah R.</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Smeesters</surname>
                    <given-names>Pierre R.</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                  <xref ref-type="aff" rid="Aff2">2</xref>
                  <xref ref-type="aff" rid="Aff5">5</xref>
                  <xref ref-type="aff" rid="Aff6">6</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Steer</surname>
                    <given-names>Andrew C.</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                  <xref ref-type="aff" rid="Aff3">3</xref>
                  <xref ref-type="aff" rid="Aff4">4</xref>
                </contrib>
                <aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.1058.c</institution-id><institution-id institution-id-type="ISNI">0000 0000 9442 535X</institution-id><institution>Tropical Diseases Research Group, </institution><institution>Murdoch Childrens Research Institute, </institution></institution-wrap>Melbourne, Victoria Australia </aff>
                <aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="GRID">grid.4989.c</institution-id><institution-id institution-id-type="ISNI">0000 0001 2348 0746</institution-id><institution>Department of Paediatrics, </institution><institution>Universit Libre de Bruxelles, </institution></institution-wrap>Brussels, Belgium </aff>
                <aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="GRID">grid.1008.9</institution-id><institution-id institution-id-type="ISNI">0000 0001 2179 088X</institution-id><institution>Department of Paediatrics, </institution><institution>University of Melbourne, </institution></institution-wrap>Melbourne, Victoria Australia </aff>
                <aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="GRID">grid.416107.5</institution-id><institution-id institution-id-type="ISNI">0000 0004 0614 0346</institution-id><institution>Infectious Diseases Unit, Department of General Medicine, </institution><institution>The Royal Childrens Hospital Melbourne, </institution></institution-wrap>Melbourne, Victoria Australia </aff>
                <aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="GRID">grid.4989.c</institution-id><institution-id institution-id-type="ISNI">0000 0001 2348 0746</institution-id><institution>Academic Children Hospital Queen Fabiola, </institution><institution>Universit Libre de Bruxelles, </institution></institution-wrap>Brussels, Belgium </aff>
                <aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="GRID">grid.4989.c</institution-id><institution-id institution-id-type="ISNI">0000 0001 2348 0746</institution-id><institution>Molecular Bacteriology Laboratory, </institution><institution>Universit Libre de Bruxelles, </institution></institution-wrap>Brussels, Belgium </aff>
              </contrib-group>
              <pub-date pub-type="epub">
                <day>21</day>
                <month>5</month>
                <year>2021</year>
              </pub-date>
              <pub-date pub-type="pmc-release">
                <day>21</day>
                <month>5</month>
                <year>2021</year>
              </pub-date>
              <pub-date pub-type="collection">
                <year>2021</year>
              </pub-date>
              <volume>21</volume>
              <elocation-id>463</elocation-id>
              <history>
                <date date-type="received">
                  <day>2</day>
                  <month>12</month>
                  <year>2020</year>
                </date>
                <date date-type="accepted">
                  <day>12</day>
                  <month>5</month>
                  <year>2021</year>
                </date>
              </history>
              <permissions>
                <copyright-statement>Â© The Author(s) 2021</copyright-statement>
                <license>
                  <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
                  <license-p><bold>Open Access</bold>This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated in a credit line to the data.</license-p>
                </license>
              </permissions>
              <abstract id="Abs1">
                <sec>
                  <title>Background</title>
                  <p id="Par1"><italic>Streptococcus pyogenes</italic> causes a profound global burden of morbidity and mortality across its diverse clinical spectrum. To support a new controlled human infection (challenge) model seeking to accelerate <italic>S. pyogenes</italic> vaccine development, we aimed to develop an accurate and reliable molecular method for quantifying bacterial load from pharyngeal swabs collected during experimental human pharyngitis.</p>
                </sec>
                <sec>
                  <title>Methods</title>
                  <p id="Par2">Combined sequential RNA+DNA extraction from throat swabs was compared to traditional separate RNA-only and DNA-only extractions. An <italic>emm</italic>-type specific qPCR was developed to detect the <italic>emm</italic>75 challenge strain. Results from the qPCR were compared to culture, using throat swab samples collected in a human challenge study.</p>
                </sec>
                <sec>
                  <title>Results</title>
                  <p id="Par3">The qPCR was 100% specific for the <italic>emm</italic>75 challenge strain when tested against a panel of <italic>S. pyogenes emm</italic>-types and other respiratory pathogens. Combined RNA+ DNA extraction had similar yield to traditional separate extractions. The combined extraction method and <italic>emm</italic>75 qPCR had 98.8% sensitivity compared to culture for throat swabs collected from challenge study participants.</p>
                </sec>
                <sec>
                  <title>Conclusions</title>
                  <p id="Par4">We have developed a reliable molecular method for measuring <italic>S. pyogenes</italic> bacterial load from throat swabs collected in a controlled human infection model of <italic>S. pyogenes</italic> pharyngitis.</p>
                </sec>
                <sec>
                  <title>Trial registration</title>
                  <p id="Par5"><ext-link ext-link-type="uri" xlink:href="https://clinicaltrials.gov/ct2/show/NCT03361163">NCT03361163</ext-link> on 4th December 2017.</p>
                </sec>
                <sec>
                  <title>Supplementary Information</title>
                  <p>The online version contains supplementary material available at 10.1186/s12879-021-06173-w.</p>
                </sec>
              </abstract>
              <kwd-group xml:lang="en">
                <title>Keywords</title>
                <kwd>Pharyngitis</kwd>
                <kwd>Human challenge study</kwd>
                <kwd>qPCR</kwd>
                <kwd>Nucleic acid extraction</kwd>
                <kwd>
                  <italic>Streptococcus pyogenes</italic>
                </kwd>
              </kwd-group>
              <funding-group>
                <award-group>
                  <funding-source>
                    <institution-wrap>
                      <institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000925</institution-id>
                      <institution>National Health and Medical Research Council</institution>
                    </institution-wrap>
                  </funding-source>
                  <award-id>GNT1099183</award-id>
                  <principal-award-recipient>
                    <name>
                      <surname>Steer</surname>
                      <given-names>Andrew C.</given-names>
                    </name>
                  </principal-award-recipient>
                </award-group>
              </funding-group>
              <custom-meta-group>
                <custom-meta>
                  <meta-name>issue-copyright-statement</meta-name>
                  <meta-value>Â© The Author(s) 2021</meta-value>
                </custom-meta>
              </custom-meta-group>
            </article-meta>
          </front>
          <body>
            <sec id="Sec1">
              <title>Background</title>
              <p id="Par17"><italic>Streptococcus pyogenes</italic> is a human-only pathogen with a diverse clinical spectrum including severe syndromes responsible for more than 500,000 deaths worldwide each year [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>]. Hope for a vaccine to prevent <italic>S. pyogenes</italic> infections and their complications predates the identification of the bacterium in the late nineteenth century, when the disease spectrum was loosely considered under the historical umbrella term of scarlet fever. While vaccination is viewed as the intervention most likely to achieve sustainable diseases control, development has been impeded by regulatory, commercial, and scientific obstacles, including critical knowledge gaps regarding host-pathogen interactions [<xref ref-type="bibr" rid="CR3">3</xref>].</p>
              <p id="Par18">Controlled human infection (human challenge) studies recruit carefully screened volunteers who are deliberately infected under highly controlled conditions with a well-characterised strain of an infectious agent. Human models contribute to vaccine development as platforms for direct evaluation of vaccine protective efficacy and for detailed studies of bacterial pathogenesis and human immunity, spotlighting potential correlates of protection [<xref ref-type="bibr" rid="CR4">4</xref>]. A multinational collaborative group established the Controlled Human Infection for Vaccination Against <italic>Streptococcus pyogenes</italic> (CHIVAS) model of experimental human <italic>S. pyogenes</italic> pharyngitis in healthy adult volunteers in Melbourne, Australia. The first CHIVAS study (CHIVAS-M75, ClinicalTrials.gov number NCT03361163) sought to determine a dose of a carefully selected <italic>S. pyogenes</italic> M75 strain (GenBank CP033621) required to cause pharyngitis in at least 60% of participants following direct inoculation of the pharynx by a swab [<xref ref-type="bibr" rid="CR5">5</xref><xref ref-type="bibr" rid="CR7">7</xref>]. The M75 strain was isolated from a child with acute pharyngitis in Melbourne. It was selected for use as a challenge strain according to a rationale prioritising clinical relevance and participant safety, and was extensively characterised by whole genome sequencing, in vitro assays, and in an animal model of invasive infection [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR8">8</xref>].</p>
              <p id="Par19">The CHIVAS model includes serial collection of throat swabs for detection and quantification of pharyngeal <italic>S. pyogenes</italic> colonisation following the challenge procedure. We aimed to develop a robust molecular method for quantifying colonisation by the challenge strain from serial throat swabs. To study the dynamics of infection and clearance, we developed a reliable, rapid, scalable, and highly sensitive and specific method to overcome some of the limitations of traditional culture-based methods [<xref ref-type="bibr" rid="CR9">9</xref>]. Here, we describe the performance of a type-specific <italic>emm</italic>75 real-time quantitative PCR (qPCR) in testing DNA extracted from throat swabs collected during experimental human <italic>S. pyogenes</italic> pharyngitis in the CHIVAS-M75 trial.</p>
            </sec>
            <sec id="Sec2">
              <title>Methods</title>
              <sec id="Sec3">
                <title>Collection of throat swabs</title>
                <p id="Par20">Two throat swabs (FLOQswabs<sup>(R)</sup>, CopanItalia SpA) were collected on the day before challenge, approximately every 12h during an inpatient period of up to 6days, and at outpatient follow-up visits (1week, 1month and 3months after discharge). One swab was stored in 1ml eSwab (Copan Italia SpA)solution for culture onto horse blood agar (HBA) and the other swab was placed into 2ml eNat (Copan Italia SpA)nucleic acid preservation medium (guanidine thiocyanate-based solution) and stored at 20C for up to 6 months.</p>
              </sec>
              <sec id="Sec4">
                <title>Preparation of genomic DNA from different bacterial species</title>
                <p id="Par21">To assess the specificity of the <italic>emm</italic>75 qPCR assay to distinguish the <italic>S. pyogenes</italic> M75 challenge strain from other common upper respiratory tract pathogens, pellets of <italic>S. pyogenes</italic>, <italic>Streptococcus pneumoniae</italic>, <italic>Staphylococcus aureus</italic> and <italic>Haemophilus influenzae</italic> were harvested by centrifugation at 2,800 rcf from 25ml mid-log phase cultures, and colony-forming units (CFU) were enumerated by plating. Bacterial cultures were centrifuged and genomic DNA (gDNA) was isolated from pellets using the DNeasy Blood and Tissue kit (Qiagen) according to the manufacturers modifications for Gram-positive bacteria. Briefly, each bacterial pellet was incubated for 45m at 37C with 180l of enzymatic lysis buffer (lysozyme 20mg/ml, 20mM Tris-HCl pH8.0, 2mM EDTA and 1.2% v/v Triton-X), then DNA from the lysate was purified on column as per manufacturer instructions. All DNA was eluted from purification columns in a final volume of 50l. Concentration of eluted DNA was adjusted to 10<sup>4</sup> Genome Equivalents (GE)/l for all <italic>S. pyogenes</italic> strains (assuming one genome per CFU and <italic>S. pyogenes</italic> genome size of 1.8Mb). DNA from <italic>S. pneumoniae</italic> (clinical isolate, serotype 5), <italic>S. aureus</italic> (ATCC 25923) and <italic>H. influenzae</italic> (ATCC 10211) was adjusted to 10<sup>5</sup> GE/l according to their respective genome sizes (2Mb, 2.8Mb and 1.8Mb) [<xref ref-type="bibr" rid="CR10">10</xref><xref ref-type="bibr" rid="CR12">12</xref>]. Control human pharyngeal DNA was extracted from a healthy adult donor, using the DNeasy Blood and Tissue kit according to the instructions for mammalian cultured cells. For qPCR sensitivity testing, gDNA was prepared from a dilution series of M75 broth culture from 10<sup>0</sup> to 10<sup>7</sup>CFU/ml.</p>
              </sec>
              <sec id="Sec5">
                <title>Separate and combined sequential extraction of RNA and DNA</title>
                <p id="Par22">We compared RNA-only and DNA-only extractions using separate spin columns with a protocol for combined sequential RNA and then DNA extraction from the same spin column, as described by Kerllen Martins [<xref ref-type="bibr" rid="CR13">13</xref>]. In the combined RNA+DNA method, RNA was initially isolated using a a single RNeasy Mini kit column with RNase-free water (pH4.5), then DNA waseluted off the same column with elution buffer from the DNeasy Blood and Tissue kit, pH7.5 (Additionalfile<xref rid="MOESM1" ref-type="media">1</xref>: Method S1). RNA derived using either protocol was treated with the TURBO DNA-free kit (Invitrogen) to enzymatically digest contaminating DNA. The RNA was then assessed for purity and concentration by spectrophotometry using the NanoDrop 2000 system (ThermoFisher) and the 4200 TapeStation (Agilent) prokaryotic RNA High sensitivity ScreenTape Assay.</p>
              </sec>
              <sec id="Sec6">
                <title>Evaluation of extraction methods</title>
                <p id="Par23">To examine the effect of chemical pre-lysis prior to extraction, 200l volumes of eNat medium containing <italic>S. pyogenes</italic> M75 broth culture at three concentrations (910<sup>2</sup>/10<sup>4</sup>/10<sup>6</sup>CFU/ml) was stored at 20C for 7days. Using the combined RNA+DNA method, extraction was completed with and without a pre-lysis step. An additional extraction was done without pre-lysis using a larger 600l volume of spiked eNat at a single concentration (910<sup>4</sup> CFU/ml). To compare separate and combined extractions, a dilution series of <italic>S. pyogenes</italic> M75 broth culture (determined by spread-plate dilution) was combined with eNat medium for final concentrations of 310<sup>1</sup>/10<sup>2</sup>/10<sup>4/</sup>10<sup>6</sup>CFU per ml. These eNat tubes were frozen at 20C for 6weeks and extraction was performed using the RNA+DNA method without pre-lysis.</p>
              </sec>
              <sec id="Sec7">
                <title>Quantitative PCR</title>
                <p id="Par24">To assess the quality of simultaneously extracted RNA and DNA, the RNA was reverse transcribed using the Protoscript II Reverse Transcriptase kit (NEB) and the resulting cDNA and extracted gDNA were tested by qPCR. Relevant primer and probe sequences are listed in Table<xref rid="Tab1" ref-type="table">1</xref>. The <italic>emm</italic>75 assay (IDT) targets a 123bp stretch of the <italic>emm</italic>75 hypervariable region (from 146 to 268bp inclusive). Reactions using FAM-fluorescent probes (<italic>emm</italic>75 and <italic>speB</italic>) were performed using the GoTaq Probe qPCR Master Mix (Promega). GoTaq SYBR green qPCR Master Mix (Promega) was used for <italic>gyrA, lytA, gltB, hpd3</italic> and mammalian mitochondrial rRNA. Reactions were prepared using 4l of template DNA or cDNA in a final volume of 20l with primers and probes at a final concentration of 250nM. Duplicate runs were completed on an AriaMX qPCR instrument (Agilent) with the following fast 2-step conditions: initial hot start of 1cycle at 95C, followed by 40cycles of denaturation at 95C for 3s and combined annealing/extension at 60C for 30s. No template control (NTC) and no reverse transcriptase (NRT) controls were included in each assay.
<table-wrap id="Tab1"><label>Table 1</label><caption><p>Primers and probes used in this study</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Target</th><th>Gene</th><th>Primer and probe sequences (5-3)</th><th>Reference</th></tr></thead><tbody><tr><td rowspan="8"><italic>Streptococcus pyogenes</italic> M75</td><td rowspan="3"><italic>emm</italic>75</td><td>Probe: 56-FAM/TGGAAAAGT/ZEN/GAAAATGATGAGCTTCGGG/3IABkFQ</td><td rowspan="3">This study</td></tr><tr><td>F:AGTTACCATATGAAGCACGATACAA</td></tr><tr><td>R:GTTCTTCTAATCTCGTAGTCTTACCT</td></tr><tr><td rowspan="3"><italic>speB</italic></td><td>Probe: FAM-CGGCGCAGGCGGCTTCAAC-BHQ1</td><td rowspan="3">[<xref ref-type="bibr" rid="CR8">8</xref>]</td></tr><tr><td>F: CTAAACCCTTCAGCTCTTGGTACTG</td></tr><tr><td>R: TTGATGCCTACAACAGCACTTTG</td></tr><tr><td rowspan="2"><italic>gyrA</italic></td><td>F: CGACTTGTCTGAACGCCAAA</td><td rowspan="2">[<xref ref-type="bibr" rid="CR14">14</xref>]</td></tr><tr><td>R: GTCAGCAATCAAGGCCAACA</td></tr><tr><td rowspan="2"><italic>Streptococcus pneumoniae</italic></td><td rowspan="2"><italic>lytA</italic></td><td>F: ACGCAATCTAGCAGATGAAGCA</td><td rowspan="2">[<xref ref-type="bibr" rid="CR15">15</xref>]</td></tr><tr><td>R: TCGTGCGTTTTAATTCCAGCT</td></tr><tr><td rowspan="2"><italic>Staphylococcus aureus</italic></td><td rowspan="2"><italic>gltB</italic></td><td>F: CGGGTTAGGTGAATTGATTGTTTTAT</td><td rowspan="2">[<xref ref-type="bibr" rid="CR16">16</xref>]</td></tr><tr><td>R: CGCATTTGAGCTGAAGTTG</td></tr><tr><td rowspan="2"><italic>Haemophilus influenzae</italic></td><td rowspan="2"><italic>hpd3</italic></td><td>F: GGTTAAATATGCCGATGGTGTTG</td><td rowspan="2">[<xref ref-type="bibr" rid="CR17">17</xref>]</td></tr><tr><td>R: TGCATCTTTACGCACGGTGTA</td></tr><tr><td rowspan="2">Mammalian mitochondrial rRNA</td><td rowspan="2">16S <italic>mt rRNA</italic></td><td>F: CGACCTCGATGTTGGATCAG</td><td rowspan="2">[<xref ref-type="bibr" rid="CR18">18</xref>]</td></tr><tr><td>R: GAACTCAGATCACGTAGGACTTT</td></tr></tbody></table></table-wrap></p>
              </sec>
              <sec id="Sec8">
                <title>qPCR sensitivity and limit of detection</title>
                <p id="Par25">To assess the limit of detection (LOD) for the <italic>emm</italic>75 qPCR we prepared template using a 10-fold dilution series of <italic>S. pyogenes</italic> M75 gDNA (10<sup>0</sup>10<sup>7</sup>CFU/ml). Ct variation at the lowest template concentration (10<sup>0</sup>) was high so these values were excluded from calculation of the standard curve. The lowest dilution to produce consistent Ct values was 10<sup>1</sup>CFU/ml, equivalent to 40 GE of <italic>S. pyogenes</italic> M75, considered as the LOD of the <italic>emm</italic>75 qPCR. The <italic>emm</italic>75 assay was compared to a previously published qPCR targeting <italic>speB</italic>, a virulence factor in the core chromosome of <italic>S. pyogenes</italic> and highly conserved across different <italic>S. pyogenes emm</italic>-types [<xref ref-type="bibr" rid="CR8">8</xref>].</p>
              </sec>
              <sec id="Sec9">
                <title>qPCR specificity</title>
                <p id="Par26">To assess the <italic>emm</italic>-type and species specificity of the <italic>emm</italic>75 qPCR assay, 14 other <italic>S. pyogenes</italic> strains were also tested, representing each of the 11 major <italic>emm</italic> clusters (E16, D2, D4, AC35), and two single protein clades [<xref ref-type="bibr" rid="CR19">19</xref>]. Other bacteria commonly detected in the human oropharynx were also tested. The <italic>emm</italic>75 primer and probes were blasted against the online NCBI genome database (<ext-link ext-link-type="uri" xlink:href="https://blast.ncbi.nlm.nih.gov/Blast.cgi">https://blast.ncbi.nlm.nih.gov/Blast.cgi</ext-link>) to confirm the absence of homologous sequences, besides the <italic>emm</italic>75 allele.</p>
              </sec>
              <sec id="Sec10">
                <title>CHIVAS-M75 study samples</title>
                <p id="Par27">The CHIVAS-M75 study protocol has been described in detail elsewhere [<xref ref-type="bibr" rid="CR6">6</xref>]. The study was approved by the Alfred Hospital Human Research Ethics Committee (500/17). Twenty healthy adult volunteers were screened for <italic>S. pyogenes</italic> using culture and a rapid molecular point-of-care test (Abbott ID NOW Strep A 2, formerly Alere i) in the 28days prior and then again in the 12h before direct swab application of <italic>S. pyogenes</italic> M75 (at a dose of 10<sup>5</sup> CFU/ml)to the pharynx [<xref ref-type="bibr" rid="CR20">20</xref>].</p>
              </sec>
              <sec id="Sec11">
                <title>Throat swab cultures using eSwab</title>
                <p id="Par28">Each eSwab collected in the CHIVAS-M75 trial (<italic>n</italic>=192) was plated onto HBA at an external contract clinical laboratory according to the manufacturer instructions (Copan) within 48h of collection and incubated at 37C in 5% CO<sub>2</sub>. The next day, growth of -hemolytic colonies was visually estimated according to guidelines developed in our laboratory: 10-fold dilutions of <italic>S. pyogenes</italic> M75 in broth culture (range 010<sup>5</sup>CFU/ml) were prepared and an eSwab dipped into each dilution for 30s then plated on HBA for single colonies following the eSwab protocol. Semi-quantitative growth scores were established based on the results of this test: 0=no growth; 1=light; 2=moderate; 3=heavy; 4=profuse (Additionalfile<xref rid="MOESM2" ref-type="media">2</xref>: Figure S1). At the external laboratory, -hemolytic colonies were selected and confirmed as <italic>S. pyogenes</italic> by MALDI-TOF mass spectrometry (Bruker Microflex) [<xref ref-type="bibr" rid="CR21">21</xref>]. Colonies were re-plated for purity then stored at 80C. Pure vials were sent to our laboratory and all were confirmed as <italic>emm</italic>75 by gene amplification and Sanger sequencing [<xref ref-type="bibr" rid="CR22">22</xref>].</p>
              </sec>
              <sec id="Sec12">
                <title>Throat swabs for molecular analyses using eNat</title>
                <p id="Par29">Combined RNA+DNA extraction was done from 192 eNat swabs, with laboratory staff blinded to the clinical trajectory of the source participants in the CHIVAS-M75 trial. Genomic DNA was quantified by qPCR and compared to the eSwab semi-quantitative growth scores. Use of the extracted RNA to study gene bacterial and host expression (e.g., by reverse transcription-qPCR) will be the object of future work and is not explored in the methodology described herein. For determination of bacterial load in the eNat samples by <italic>emm</italic>75 qPCR: A set of standards were generated using 10-fold dilutions of <italic>S. pyogenes</italic> M75 (ranging from 10<sup>1</sup> to 10<sup>7</sup>CFU/ml) which was then used to spike eNat vials containing oropharyngeal swabs from two healthy adult donors. Standards were frozen for 7days, thawed to mimic handling of samples from the clinical trial, and DNA extracted using the combined RNA+DNA protocol. These standards were included on each 96-well plate to generate a seven-point standard curve, along with a negative no template control (NTC). Each reaction was performed in duplicate. Cycle thresholds (Ct) were ascertained with Agilent AriaMX 1.7 software using R fluorescence and automated thresholds. Reliable <italic>emm</italic>75 detection occurred at Cts 35, considered thereafter as the limit of detection (Additionalfile<xref rid="MOESM3" ref-type="media">3</xref>: Figure S2)<italic>.</italic></p>
              </sec>
              <sec id="Sec13">
                <title>Data analysis</title>
                <p id="Par30">Analyses were performed using GraphPad Prism 8 software. Efficeincy of the qPCR was calculated with Agilent AriaMX software from a formula assigning 100% when 10-fold serial dilutions of template cause an increase of 3.3cycles (i.e. linear regression slope=3.3) [<xref ref-type="bibr" rid="CR23">23</xref>]. M75 bacterial load was expressed as log<sub>10</sub>
<italic>emm</italic>75 genome equivalents (GE) per ml of eNat medium. Separate or combined column extractions were compared by paired t-tests and the non-parametric Spearman coefficient was used to consider correlation between plate growth scores and <italic>emm</italic>75 GE [<xref ref-type="bibr" rid="CR8">8</xref>].</p>
              </sec>
            </sec>
            <sec id="Sec14">
              <title>Results</title>
              <sec id="Sec15">
                <title>qPCR sensitivity</title>
                <p id="Par31">The <italic>emm</italic>75 qPCR assay had superior efficiency of 99.2% based on a slope of 3.3 (R<sup>2</sup>=0.999) (Fig.<xref rid="Fig1" ref-type="fig">1</xref>). In comparison, the <italic>speB</italic> assay had 96.5% efficiency (slope=3.4, R<sup>2</sup>=0.999). Ct values for the <italic>speB</italic> assay were marginally lower than the <italic>emm</italic>75 assay (mean difference 0.56 Ct, 95% CI [0.40, 0.73]), however the assays had similar levels of sensitivity, with lower limits of detection of 40 GE/ml when corrected for efficiency.
<fig id="Fig1"><label>Fig. 1</label><caption><p>Performance of the <italic>emm</italic>75 qPCR. qPCR targeting the <italic>emm75</italic> or <italic>speB</italic> gene was performed on genomic DNA isolated from 10-fold dilutions of <italic>S. pyogenes</italic> M75. The <italic>speB</italic> qPCR was used to provide a benchmark for the performance of the <italic>emm75</italic> qPCR, using FAM-conjugated probes for both reactions. Each point represents the mean and standard deviation (SD) of duplicate reactions</p></caption><graphic xlink:href="12879_2021_6173_Fig1_HTML" id="MO1"/></fig></p>
              </sec>
              <sec id="Sec16">
                <title>qPCR specificity</title>
                <p id="Par32">The <italic>emm</italic>75 qPCR was 100% specific within the detectable concentration range, producing an amplification signal for assays containing <italic>emm</italic>75 template and no signal for assays containing non-<italic>emm</italic>75 <italic>S. pyogenes</italic>, <italic>S. pneumoniae</italic>, <italic>S. aureus</italic>, <italic>H. influenzae</italic> or DNA extracted from pharyngeal swabs from a healthy adult. The <italic>speB</italic> qPCR was 100% specific, being positive for all 15<italic>S. pyogenes</italic> templates and negative for the other bacterial species tested (all 4 species were positive in relevant species-specific assays) (Additionalfile<xref rid="MOESM4" ref-type="media">4</xref>: Table S1).</p>
              </sec>
              <sec id="Sec17">
                <title>Evaluation of extraction methods</title>
                <p id="Par33">Effective extraction of DNA from Gram-positive bacteria such as <italic>S. pyogenes</italic> usually requires an enzymatic peptidoglycan digestion step to lyse the cell wall. The eNat medium contains lysing agents, so that a pre-lysis incubation step or addition of supplemental lytic agents may not be required. We performed DNA extraction with and without an enzymatic pre-lysis step to assess whether this influenced DNA yield in the <italic>emm</italic>75 qPCR. At each dilution tested, pre-lysis generated lower Cts than extraction without pre-lysis (mean difference 0.9458 Ct, <italic>P</italic> value=0.03, 95% CI [0.28, 1.61]; Fig.<xref rid="Fig2" ref-type="fig">2</xref>a). When a higher volume of eNat medium was processed through the column without pre-lysis (600l versus 200l, both 910<sup>4</sup> CFU/ml) the mean Ct was 26.39 (Fig. <xref rid="Fig2" ref-type="fig">2</xref>a,)- lower than the extrapolated 27.27 for the equivalent bacterial load with pre-lysis (pre-lysis linear regression: Ct=[2.914.73]+41.05). Although not tested across a range of input bacteria CFUs, this finding suggests that increasing the processing volume of eNat is more effective for increasing DNA yield than applying a pre-lysis step.
<fig id="Fig2"><label>Fig. 2</label><caption><p>Optimisation of the method for isolation of DNA and RNA from throat swabs in eNat. <bold>a</bold> Pre-lysis versus No pre-lysis extractions using the combined RNA+DNA approach. eNats were spiked with <italic>S. pyogenes</italic> M75 at three concentrations and 200l aliquots (1.810<sup>2</sup>, 1.810<sup>4</sup>, 1.810<sup>6</sup> total GE) underwent DNA extraction using a chemical Pre-lysis step () or No pre-lysis (). A larger 600l aliquot (3x vol) of eNat medium spiked with M75 (5.410<sup>4</sup> total GE) was processed without pre-lysis (). Data shown in total GE to account for differences in input bacteria. Each point represents the mean and SD of two eNats tested in duplicate qPCRs. <bold>b</bold> eNats containing a range of M75 were used to test separate column extractions (RNA-only or DNA-only ) versus combined RNA+DNA isolation (RNA<bold/> and DNA<bold/>). The <italic>emm75</italic> qPCR was used to assess DNA whilst RNA was converted to cDNA and tested in a SYBR Green qPCR for the housekeeping gene, <italic>gyrA.</italic> Each point represents the mean and SD of three eNats tested in duplicate qPCRs targeting the <italic>emm75</italic> gene</p></caption><graphic xlink:href="12879_2021_6173_Fig2_HTML" id="MO2"/></fig></p>
                <p id="Par34">DNA yield from the combined RNA+DNA extraction protocol was lower than the DNA-only method as determined by UV absorbance and qPCR (mean difference 2.4 Ct, <italic>P</italic> value=0.03, 95% CI [0.38, 4.3]; Fig. <xref rid="Fig2" ref-type="fig">2</xref>b, Additionalfile<xref rid="MOESM5" ref-type="media">5</xref>: Table S3). As expected, for RNA (and resulting cDNA) both extraction protocols achieved similar Ct values and limits of detection in a qPCR assay targeting the <italic>S. pyogenes</italic> housekeeping gene <italic>gyrA</italic> (mean difference 0.08 Ct, P value 0.93, 95% CI [2.57 to 2.73]; Fig. <xref rid="Fig2" ref-type="fig">2</xref>b). NanoDrop and TapeStation systems did not produce consistent estimations of RNA concentration and quality due to low concentration (Additionalfile<xref rid="MOESM6" ref-type="media">6</xref>: Table S3). As results were similar and the combined extraction protocol reduced both time and cost of extraction, this method was used for the CHIVAS-M75 study samples.</p>
              </sec>
              <sec id="Sec18">
                <title>Detection of <italic>emm</italic>75 bacterial load in vivo by qPCR</title>
                <p id="Par35">During the CHIVAS-M75 study, 20 participants were challenged with 10<sup>5</sup> CFU/ml of M75,and 192 paired throat swabs (between 8 and 14 time points per participant) were collected for culture (eSwab) and molecular testing (eNat). There was high correlation between culture and qPCR results (Spearman correlation R=0.8058, <italic>P</italic>&lt;0.001; Fig.<xref rid="Fig3" ref-type="fig">3</xref>).
<fig id="Fig3"><label>Fig. 3</label><caption><p>Correlation between culture and qPCR results. The number of <italic>emm</italic>75 genome equivalents (GE), extrapolated from qPCR Ct values, was compared to plate growth scores derived by culture. The median log10 <italic>emm</italic>75 GE of each score is represented by the dotted line (---), whilst the width of the shape reflects the density of data at the respective values</p></caption><graphic xlink:href="12879_2021_6173_Fig3_HTML" id="MO3"/></fig></p>
                <p id="Par36">Culture and qPCR results were concordant (positive or negative) for 171 of 192 evaluable sample pairs (89.1%) (Table<xref rid="Tab2" ref-type="table">2</xref>). All paired swabs taken prior to challenge were negative by both qPCR and culture. One culture-positive eSwab was negative by qPCR, giving a sensitivity of 98.8% (95% CI [97.3, 100]) for the qPCR assay. Swabs for 20 time points were qPCR positive and culture negative, including 16 collected after antibiotic treatment and 4 from the first 48h after challenge in participants whose subsequent swabs were culture positive (Additionalfile<xref rid="MOESM7" ref-type="media">7</xref>: Table S4). All culture-positive swabs were verified as <italic>S. pyogenes</italic> M75 by qPCR and <italic>emm</italic> typing.
<table-wrap id="Tab2"><label>Table 2</label><caption><p>Test results for culture and qPCR from throat swabs</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" colspan="2"/><th colspan="2"><bold>Culture</bold></th><th rowspan="2"><bold>Total PCR</bold></th></tr><tr><th><bold>+</bold></th><th><bold/></th></tr></thead><tbody><tr><td rowspan="2"><bold>PCR</bold></td><td><bold>+</bold></td><td>83</td><td>20</td><td>103 (53.6%)</td></tr><tr><td><bold/></td><td>1</td><td>88</td><td>89 (46.4%)</td></tr><tr><td colspan="2"><bold>Total culture</bold></td><td>84 (43.7%)</td><td>108 (56.3%)</td><td>192 (100%)</td></tr></tbody></table><table-wrap-foot><p>A positive qPCR result is defined by a Ct35 as determined by a seven-point standard curve run on each qPCR. A positive culture result is defined by a plate growth score1</p></table-wrap-foot></table-wrap></p>
              </sec>
            </sec>
            <sec id="Sec19">
              <title>Discussion</title>
              <p id="Par37">We have developed a sensitive and specific quantitative PCR assay for measurement of <italic>S. pyogenes</italic> M75 from throat swabs in a human infection study of <italic>S. pyogenes</italic> pharyngitis. We have shown that the qPCR is specific for the <italic>emm</italic>75 gene encoded by the challenge strain with a high level of analytical performance for efficiency, specificity, and sensitivity. A lysis step prior to extraction of DNA from throat swabs stored in eNat was not critical for DNA extraction, attributable to bacterial lysis by the proprietary reagents in the eNat medium. There were only minor differences in yield between separate RNA-only and DNA-only extractions and combined RNA+DNA isolation using a single RNeasy column. The combined approach was simpler, faster, and enabled processing of the entire 2ml eNat volume using a single column, reducing cost. Although not the primary aim of this study, the ability to extract quality cDNA from RNA, in addition to DNA for bacterial load quantification, increases the potential value of this technique. Finally, we compared qPCR results to semi-quantitative culture scores ('no growth' score of 0 is quantitative), showing the performance of the assay for its intended use- to measure bacterial load from throat swabs collected in a human challenge study.</p>
              <p id="Par38">Several studies have shown that qPCR is highly sensitive compared to culture and can be used to accurately quantify bacterial load during natural <italic>S. pyogenes</italic> pharyngitis [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR24">24</xref><xref ref-type="bibr" rid="CR27">27</xref>].</p>
              <p id="Par39">The <italic>emm</italic>75 qPCR assay we developed is rapid, scalable, and type-specific. The entire process from DNA extraction to qPCR can provide a fully quantitative result in 4h and can be performed on swabs stored in eNat solution for at least 6months without loss of DNA yield. The contract clinical trials facility for the CHIVAS-M75 study was offsite, with limited local laboratory capabilities, so that stability during storage and transport was critical. In comparison, the combined processes for <italic>S. pyogenes</italic> M75 enumeration and <italic>emm</italic>-typing by traditional methods requires at least 7days (initial culture, purity plating, speciation, group typing, extraction of DNA, <italic>emm</italic> gene sequencing and analysis).</p>
              <p id="Par40">Historically, human infection studies for bacterial pathogens (including <italic>S. pyogenes</italic> pharyngitis studies in the 1970s) have used traditional bacterial culture methods to measure bacterial load during experimental infection [<xref ref-type="bibr" rid="CR28">28</xref><xref ref-type="bibr" rid="CR31">31</xref>]. Several non-human primate models of <italic>S. pyogenes</italic> pharyngitis have performed PCR for sample analysis (mainly for gene expression or to confirm the <italic>emm</italic>-type), however plate enumeration was the principal method to quantify bacterial load [<xref ref-type="bibr" rid="CR32">32</xref><xref ref-type="bibr" rid="CR35">35</xref>].</p>
              <p id="Par41">We found a strong correlation between <italic>emm</italic>75 qPCR Ct values and plate growth scores. Discrepancies were noted in 20 swab pairs that were qPCR positive and culture negative, early after challenge as bacterial load was increasing or after initiation of antibiotic treatment when <italic>S. pyogenes</italic> M75 colonisation was waning. These data likely reflect the lower limit of detection and higher sensitivity of qPCR compared to culture, and detection of non-culturable bacterial elements [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR36">36</xref>]. Reduced sensitivity of bacterial culture following antibiotic treatment is common [<xref ref-type="bibr" rid="CR37">37</xref>]. Molecular methods have also shown higher sensitivity in studies using other human pathogens, especially following antibiotic treatment [<xref ref-type="bibr" rid="CR38">38</xref>, <xref ref-type="bibr" rid="CR39">39</xref>]. There was a single pair of discordant qPCR negative and culture positive swabs, collected after antibiotic treatment. Subsequent swabs were negative by both techniques. This discrepancy is likely explained by variation in swab collection. All volunteers returned a negative qPCR result within 7days of discharge, showing the usefulness of qPCR in differentiating persistent colonisation from relapse or re-infection during the period of outpatient follow up.</p>
              <p id="Par42">This study has several limitations. The categorical and semi-quantitative plate growth scoring system clouds direct comparison to continuous qPCR data. The eSwabs for culture were collected at the off-site commercial trials facility and transferred to a contracted laboratory for culture according to diagnostic protocols and workflows with semi-quantitative enumeration as an additional step. The eNat swabs were immediately frozen and later transported to our research laboratory for batched molecular testing. This variation could conceivably have contributed to differences between culture and qPCR results. Detection of bacterial DNA from non-viable bacteria may cause false-positive results by qPCR. For the CHIVAS-M75 trial, qPCR detection was at least equivalent to culture. Even more precise bacterial quantification could be overcome if desired in future studies using a marker of viability. As discussed, further work remains to be done with RNA extracted from throat swabs collected in the CHIVAS-M75 trial.</p>
            </sec>
            <sec id="Sec20">
              <title>Conclusions</title>
              <p id="Par43">We have developed a reliable, rapid, scalable, and highly sensitive and specific molecular method to quantify pharyngeal colonisation by <italic>S. pyogenes</italic> M75 in a controlled human infection model.</p>
            </sec>
            <sec sec-type="supplementary-material">
              <title>Supplementary Information</title>
              <sec id="Sec21">
                <p>
                  <supplementary-material content-type="local-data" id="MOESM1">
                    <media xlink:href="12879_2021_6173_MOESM1_ESM.pdf">
                      <caption>
                        <p><bold>Additional file 1: Method S1.</bold> The protocol for combined RNA and DNA extraction from eNat medium containing participant throat swabs.</p>
                      </caption>
                    </media>
                  </supplementary-material>
                  <supplementary-material content-type="local-data" id="MOESM2">
                    <media xlink:href="12879_2021_6173_MOESM2_ESM.pdf">
                      <caption>
                        <p><bold>Additional file 2: Figure S1.</bold> Visual guidelines for semi-quantitative scoring of the <italic>S. pyogenes</italic> M75 challenge strain from eSwabs.</p>
                      </caption>
                    </media>
                  </supplementary-material>
                  <supplementary-material content-type="local-data" id="MOESM3">
                    <media xlink:href="12879_2021_6173_MOESM3_ESM.pdf">
                      <caption>
                        <p><bold>Additional file 3: Figure S2.</bold> Standard curve for determination of <italic>emm</italic>75 GE in eNats by qPCR. Seven-point standard curves were included on each <italic>emm</italic>75 qPCR plate and used to extrapolate bacterial load for eNat throat swabs from the CHIVAS-M75 trial, expressed as <italic>emm</italic>75 genome equivalents (GE) per ml of eNat medium. The dotted line represents the limit of detection Ct35. Mean and standard deviation shown from 7 duplicate runs.</p>
                      </caption>
                    </media>
                  </supplementary-material>
                  <supplementary-material content-type="local-data" id="MOESM4">
                    <media xlink:href="12879_2021_6173_MOESM4_ESM.pdf">
                      <caption>
                        <p><bold>Additional file 4: Table S1.</bold> Specificity of the <italic>emm</italic>75 qPCR. <italic>S. pyogenes</italic> from different <italic>emm</italic>-clusters and other respiratory pathogens were used to demonstrate the specificity of the <italic>emm</italic>75 qPCR. Each value is the mean of duplicate reactions. Samples with no provided Ct value failed to cross the fluorescence threshold by the 40th (last) cycle of the assay and all samples with Ct values greater than 35 were considered negative. No template control was included and this did not cross the fluorescence threshold by the 40th cycle.</p>
                      </caption>
                    </media>
                  </supplementary-material>
                  <supplementary-material content-type="local-data" id="MOESM5">
                    <media xlink:href="12879_2021_6173_MOESM5_ESM.pdf">
                      <caption>
                        <p><bold>Additional file 5: Table S2.</bold><italic>Emm</italic>75 qPCR and NanoDrop DNA readings. Comparison between DNA-only and single column combined extraction methods (RNA eluted first). Refer to Fig. <xref rid="Fig2" ref-type="fig">2</xref>b DNA readings.</p>
                      </caption>
                    </media>
                  </supplementary-material>
                  <supplementary-material content-type="local-data" id="MOESM6">
                    <media xlink:href="12879_2021_6173_MOESM6_ESM.pdf">
                      <caption>
                        <p><bold>Additional file 6: Table S3.</bold><italic>gyrA</italic> RT-qPCR and NanoDrop RNA readings. Comparison between RNA-only and single column combined extraction methods (RNA eluted first). Refer to Fig. <xref rid="Fig2" ref-type="fig">2</xref>b RNA readings.</p>
                      </caption>
                    </media>
                  </supplementary-material>
                  <supplementary-material content-type="local-data" id="MOESM7">
                    <media xlink:href="12879_2021_6173_MOESM7_ESM.pdf">
                      <caption>
                        <p><bold>Additional file 7: Table S4.</bold> Detailed timeline of discrepancies between culture and qPCR results. Twenty swabs were positive by <italic>emm</italic>75 qPCR and negative by culture. These swabs were either collected within 48h after inoculation (<italic>N</italic>=4) or within 36h after initiation of antibiotic treatment (<italic>N</italic>=16). 0, pre challenge; +24, 24h post challenge; Abx, antibiotics; +1 w, 1week post discharge; +1m, 1month post discharge; +3m, 3months post discharge.</p>
                      </caption>
                    </media>
                  </supplementary-material>
                </p>
              </sec>
            </sec>
          </body>
          <back>
            <glossary>
              <title>Abbreviations</title>
              <def-list>
                <def-item>
                  <term>cDNA</term>
                  <def>
                    <p id="Par6">Complementary DNA</p>
                  </def>
                </def-item>
                <def-item>
                  <term>CHIVAS</term>
                  <def>
                    <p id="Par7">Controlled Human Infection for Vaccination Against <italic>Streptococcus pyogenes</italic></p>
                  </def>
                </def-item>
                <def-item>
                  <term>CI</term>
                  <def>
                    <p id="Par8">Confidence interval</p>
                  </def>
                </def-item>
                <def-item>
                  <term>Ct</term>
                  <def>
                    <p id="Par9">Cycle thresholds</p>
                  </def>
                </def-item>
                <def-item>
                  <term>gDNA</term>
                  <def>
                    <p id="Par10">Genomic DNA</p>
                  </def>
                </def-item>
                <def-item>
                  <term>GE</term>
                  <def>
                    <p id="Par11">Genome equivalents</p>
                  </def>
                </def-item>
                <def-item>
                  <term>NRT</term>
                  <def>
                    <p id="Par12">No reverse transcriptase</p>
                  </def>
                </def-item>
                <def-item>
                  <term>NTC</term>
                  <def>
                    <p id="Par13">No template control</p>
                  </def>
                </def-item>
                <def-item>
                  <term>qPCR</term>
                  <def>
                    <p id="Par14">Real-time quantitative polymerase chain reaction</p>
                  </def>
                </def-item>
                <def-item>
                  <term>
                    <italic>S. pyogenes</italic>
                  </term>
                  <def>
                    <p id="Par15">
                      <italic>Streptococcus pyogenes</italic>
                    </p>
                  </def>
                </def-item>
                <def-item>
                  <term><italic>S. pyogenes</italic> M75</term>
                  <def>
                    <p id="Par16"><italic>Streptococcus pyogenes</italic> M75 challenge strain (ID 611024)</p>
                  </def>
                </def-item>
              </def-list>
            </glossary>
            <fn-group>
              <fn>
                <p>
                  <bold>Publishers Note</bold>
                </p>
                <p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
              </fn>
              <fn>
                <p>Loraine V. Fabri and Kristy I. Azzopardi contributed equally to this work.</p>
              </fn>
            </fn-group>
            <ack>
              <title>Acknowledgements</title>
              <p>Thank you to Dr. Jonathan Jacobson and Associate Professor Catherine Satzke for providing the <italic>S. pneumoniae, S. aureus</italic> and <italic>H. influenzae</italic> genomic DNA.</p>
              <sec id="FPar1">
                <title>Sponsor</title>
                <p id="Par44">Murdoch Childrens Research Institute.</p>
              </sec>
            </ack>
            <notes notes-type="author-contribution">
              <title>Authors contributions</title>
              <p>ACS was the chief investigator for the CHIVAS-M75 study and planned this study with KIA and JO. Experimental design, experiments, statistical analysis, and preparation of the first draft of the manuscript was done by LF and KIA. HF and PS reviewed and edited manuscript drafts. All authors critically reviewed and approved the final version.</p>
            </notes>
            <notes notes-type="funding-information">
              <title>Funding</title>
              <p>This work is supported by the Australian National Health and Medical Research Council [GNT1099183]. Loraine Fabri is supported by a grant from The Belgian Kids Fund for Pediatric Research.</p>
            </notes>
            <notes notes-type="data-availability">
              <title>Availability of data and materials</title>
              <p>All data generated and analysed during the study are included in this published article and its additional supplementary files. Raw datasets are available from the corresponding author on reasonable request.</p>
            </notes>
            <notes>
              <title>Declarations</title>
              <notes id="FPar2">
                <title>Ethics approval and consent to participate</title>
                <p id="Par45">The CHIVAS study was approved by the Alfred Hospital Human Research Ethics Committee (500/17). Written informed consent was obtained from all participants.</p>
              </notes>
              <notes id="FPar3">
                <title>Consent for publication</title>
                <p id="Par46">Not applicable.</p>
              </notes>
              <notes id="FPar4" notes-type="COI-statement">
                <title>Competing interests</title>
                <p id="Par47">The authors declare that they have no competing interests.</p>
              </notes>
            </notes>
            <ref-list id="Bib1">
              <title>References</title>
              <ref id="CR1">
                <label>1.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Carapetis</surname>
                      <given-names>JR</given-names>
                    </name>
                    <name>
                      <surname>Steer</surname>
                      <given-names>AC</given-names>
                    </name>
                    <name>
                      <surname>Mulholland</surname>
                      <given-names>EK</given-names>
                    </name>
                    <name>
                      <surname>Weber</surname>
                      <given-names>M</given-names>
                    </name>
                  </person-group>
                  <article-title>The global burden of group a streptococcal diseases</article-title>
                  <source>Lancet Infect Dis</source>
                  <year>2005</year>
                  <volume>5</volume>
                  <issue>11</issue>
                  <fpage>685</fpage>
                  <lpage>694</lpage>
                  <pub-id pub-id-type="doi">10.1016/S1473-3099(05)70267-X</pub-id>
                  <?supplied-pmid 16253886?>
                  <pub-id pub-id-type="pmid">16253886</pub-id>
                </element-citation>
              </ref>
              <ref id="CR2">
                <label>2.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Walker</surname>
                      <given-names>MJ</given-names>
                    </name>
                    <name>
                      <surname>Barnett</surname>
                      <given-names>TC</given-names>
                    </name>
                    <name>
                      <surname>McArthur</surname>
                      <given-names>JD</given-names>
                    </name>
                    <name>
                      <surname>Cole</surname>
                      <given-names>JN</given-names>
                    </name>
                    <name>
                      <surname>Gillen</surname>
                      <given-names>CM</given-names>
                    </name>
                    <name>
                      <surname>Henningham</surname>
                      <given-names>A</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Disease manifestations and pathogenic mechanisms of group a streptococcus</article-title>
                  <source>Clin Microbiol Rev</source>
                  <year>2014</year>
                  <volume>27</volume>
                  <issue>2</issue>
                  <fpage>264</fpage>
                  <lpage>301</lpage>
                  <pub-id pub-id-type="doi">10.1128/CMR.00101-13</pub-id>
                  <?supplied-pmid 3993104?>
                  <pub-id pub-id-type="pmid">24696436</pub-id>
                </element-citation>
              </ref>
              <ref id="CR3">
                <label>3.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Steer</surname>
                      <given-names>AC</given-names>
                    </name>
                    <name>
                      <surname>Carapetis</surname>
                      <given-names>JR</given-names>
                    </name>
                    <name>
                      <surname>Dale</surname>
                      <given-names>JB</given-names>
                    </name>
                    <name>
                      <surname>Fraser</surname>
                      <given-names>JD</given-names>
                    </name>
                    <name>
                      <surname>Good</surname>
                      <given-names>MF</given-names>
                    </name>
                    <name>
                      <surname>Guilherme</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Moreland</surname>
                      <given-names>NJ</given-names>
                    </name>
                    <name>
                      <surname>Mulholland</surname>
                      <given-names>EK</given-names>
                    </name>
                    <name>
                      <surname>Schodel</surname>
                      <given-names>F</given-names>
                    </name>
                    <name>
                      <surname>Smeesters</surname>
                      <given-names>PR</given-names>
                    </name>
                  </person-group>
                  <article-title>Status of research and development of vaccines for streptococcus pyogenes</article-title>
                  <source>Vaccine.</source>
                  <year>2016</year>
                  <volume>34</volume>
                  <issue>26</issue>
                  <fpage>2953</fpage>
                  <lpage>2958</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.vaccine.2016.03.073</pub-id>
                  <?supplied-pmid 27032515?>
                  <pub-id pub-id-type="pmid">27032515</pub-id>
                </element-citation>
              </ref>
              <ref id="CR4">
                <label>4.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Stanisic</surname>
                      <given-names>DI</given-names>
                    </name>
                    <name>
                      <surname>McCarthy</surname>
                      <given-names>JS</given-names>
                    </name>
                    <name>
                      <surname>Good</surname>
                      <given-names>MF</given-names>
                    </name>
                  </person-group>
                  <article-title>Controlled human malaria infection: applications, advances, and challenges</article-title>
                  <source>Infect Immun</source>
                  <year>2018</year>
                  <volume>86</volume>
                  <issue>1</issue>
                  <fpage>e00479</fpage>
                  <lpage>e00417</lpage>
                  <?supplied-pmid 28923897?>
                  <pub-id pub-id-type="pmid">28923897</pub-id>
                </element-citation>
              </ref>
              <ref id="CR5">
                <label>5.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Osowicki</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Azzopardi</surname>
                      <given-names>KI</given-names>
                    </name>
                    <name>
                      <surname>McIntyre</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Rivera-Hernandez</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Ong</surname>
                      <given-names>CY</given-names>
                    </name>
                    <name>
                      <surname>Baker</surname>
                      <given-names>C</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>A controlled human infection model of group A streptococcus pharyngitis: which strain and why?</article-title>
                  <source>mSphere</source>
                  <year>2019</year>
                  <volume>4</volume>
                  <issue>1</issue>
                  <fpage>e00647</fpage>
                  <lpage>e00618</lpage>
                  <pub-id pub-id-type="doi">10.1128/mSphere.00647-18</pub-id>
                </element-citation>
              </ref>
              <ref id="CR6">
                <label>6.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Osowicki</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Azzopardi</surname>
                      <given-names>KI</given-names>
                    </name>
                    <name>
                      <surname>Baker</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Waddington</surname>
                      <given-names>CS</given-names>
                    </name>
                    <name>
                      <surname>Pandey</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Schuster</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Grobler</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Cheng</surname>
                      <given-names>AC</given-names>
                    </name>
                    <name>
                      <surname>Pollard</surname>
                      <given-names>AJ</given-names>
                    </name>
                    <name>
                      <surname>McCarthy</surname>
                      <given-names>JS</given-names>
                    </name>
                    <name>
                      <surname>Good</surname>
                      <given-names>MF</given-names>
                    </name>
                    <name>
                      <surname>Walker</surname>
                      <given-names>MJ</given-names>
                    </name>
                    <name>
                      <surname>Dale</surname>
                      <given-names>JB</given-names>
                    </name>
                    <name>
                      <surname>Batzloff</surname>
                      <given-names>MR</given-names>
                    </name>
                    <name>
                      <surname>Carapetis</surname>
                      <given-names>JR</given-names>
                    </name>
                    <name>
                      <surname>Smeesters</surname>
                      <given-names>PR</given-names>
                    </name>
                    <name>
                      <surname>Steer</surname>
                      <given-names>AC</given-names>
                    </name>
                  </person-group>
                  <article-title>Controlled human infection for vaccination against streptococcus pyogenes (CHIVAS): establishing a group a streptococcus pharyngitis human infection study</article-title>
                  <source>Vaccine.</source>
                  <year>2019</year>
                  <volume>37</volume>
                  <issue>26</issue>
                  <fpage>3485</fpage>
                  <lpage>3494</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.vaccine.2019.03.059</pub-id>
                  <?supplied-pmid 31101422?>
                  <pub-id pub-id-type="pmid">31101422</pub-id>
                </element-citation>
              </ref>
              <ref id="CR7">
                <label>7.</label>
                <mixed-citation publication-type="other">Osowicki J, Azzopardi KI, Fabri L, Frost HR, Rivera-Hernandez T, Neeland MR, et al. A controlled human infection model of Streptococcus pyogenes pharyngitis: an observational, dose-finding study (CHIVAS-M75). Lancet Microbe. 2021.10.1016/S2666-5247(20)30240-8.</mixed-citation>
              </ref>
              <ref id="CR8">
                <label>8.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Dunne</surname>
                      <given-names>EM</given-names>
                    </name>
                    <name>
                      <surname>Marshall</surname>
                      <given-names>JL</given-names>
                    </name>
                    <name>
                      <surname>Baker</surname>
                      <given-names>CA</given-names>
                    </name>
                    <name>
                      <surname>Manning</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Gonis</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Danchin</surname>
                      <given-names>MH</given-names>
                    </name>
                    <name>
                      <surname>Smeesters</surname>
                      <given-names>PR</given-names>
                    </name>
                    <name>
                      <surname>Satzke</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Steer</surname>
                      <given-names>AC</given-names>
                    </name>
                  </person-group>
                  <article-title>Detection of group a streptococcal pharyngitis by quantitative PCR</article-title>
                  <source>BMC Infect Dis</source>
                  <year>2013</year>
                  <volume>13</volume>
                  <issue>1</issue>
                  <fpage>312</fpage>
                  <pub-id pub-id-type="doi">10.1186/1471-2334-13-312</pub-id>
                  <?supplied-pmid 23844865?>
                  <pub-id pub-id-type="pmid">23844865</pub-id>
                </element-citation>
              </ref>
              <ref id="CR9">
                <label>9.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Oliver</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Malliya Wadu</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Pierse</surname>
                      <given-names>N</given-names>
                    </name>
                    <name>
                      <surname>Moreland</surname>
                      <given-names>NJ</given-names>
                    </name>
                    <name>
                      <surname>Williamson</surname>
                      <given-names>DA</given-names>
                    </name>
                    <name>
                      <surname>Baker</surname>
                      <given-names>MG</given-names>
                    </name>
                  </person-group>
                  <article-title>Group a streptococcus pharyngitis and pharyngeal carriage: a meta-analysis</article-title>
                  <source>PLoS Negl Trop Dis</source>
                  <year>2018</year>
                  <volume>12</volume>
                  <issue>3</issue>
                  <fpage>e0006335</fpage>
                  <pub-id pub-id-type="doi">10.1371/journal.pntd.0006335</pub-id>
                  <?supplied-pmid 29554121?>
                  <pub-id pub-id-type="pmid">29554121</pub-id>
                </element-citation>
              </ref>
              <ref id="CR10">
                <label>10.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Camilli</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Bonnal</surname>
                      <given-names>RJ</given-names>
                    </name>
                    <name>
                      <surname>Del Grosso</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Iacono</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Corti</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Rizzi</surname>
                      <given-names>E</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Complete genome sequence of a serotype 11A, ST62 Streptococcus pneumoniae invasive isolate</article-title>
                  <source>BMC Microbiol</source>
                  <year>2011</year>
                  <volume>11</volume>
                  <issue>1</issue>
                  <fpage>25</fpage>
                  <pub-id pub-id-type="doi">10.1186/1471-2180-11-25</pub-id>
                  <?supplied-pmid 21284853?>
                  <pub-id pub-id-type="pmid">21284853</pub-id>
                </element-citation>
              </ref>
              <ref id="CR11">
                <label>11.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Treangen</surname>
                      <given-names>TJ</given-names>
                    </name>
                    <name>
                      <surname>Maybank</surname>
                      <given-names>RA</given-names>
                    </name>
                    <name>
                      <surname>Enke</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Friss</surname>
                      <given-names>MB</given-names>
                    </name>
                    <name>
                      <surname>Diviak</surname>
                      <given-names>LF</given-names>
                    </name>
                    <name>
                      <surname>Karaolis</surname>
                      <given-names>DK</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Complete genome sequence of the quality control strain <italic>Staphylococcus aureus subsp. aureus</italic> ATCC 25923</article-title>
                  <source>Genome Announc</source>
                  <year>2014</year>
                  <volume>2</volume>
                  <issue>6</issue>
                  <fpage>e01110</fpage>
                  <lpage>e01114</lpage>
                  <pub-id pub-id-type="doi">10.1128/genomeA.01110-14</pub-id>
                  <pub-id pub-id-type="pmid">25377701</pub-id>
                </element-citation>
              </ref>
              <ref id="CR12">
                <label>12.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Fleischmann</surname>
                      <given-names>RD</given-names>
                    </name>
                    <name>
                      <surname>Adams</surname>
                      <given-names>MD</given-names>
                    </name>
                    <name>
                      <surname>White</surname>
                      <given-names>O</given-names>
                    </name>
                    <name>
                      <surname>Clayton</surname>
                      <given-names>RA</given-names>
                    </name>
                    <name>
                      <surname>Kirkness</surname>
                      <given-names>EF</given-names>
                    </name>
                    <name>
                      <surname>Kerlavage</surname>
                      <given-names>AR</given-names>
                    </name>
                    <name>
                      <surname>Bult</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Tomb</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Dougherty</surname>
                      <given-names>B</given-names>
                    </name>
                    <name>
                      <surname>Merrick</surname>
                      <given-names>J</given-names>
                    </name>
                  </person-group>
                  <article-title>Whole-genome random sequencing and assembly of Haemophilus influenzae Rd</article-title>
                  <source>Science.</source>
                  <year>1995</year>
                  <volume>269</volume>
                  <issue>5223</issue>
                  <fpage>496</fpage>
                  <lpage>512</lpage>
                  <pub-id pub-id-type="doi">10.1126/science.7542800</pub-id>
                  <?supplied-pmid 7542800?>
                  <pub-id pub-id-type="pmid">7542800</pub-id>
                </element-citation>
              </ref>
              <ref id="CR13">
                <label>13.</label>
                <mixed-citation publication-type="other">Kerllen Martins W. A useful procedure to isolate simultaneously DNA and RNA from a single tumor sample. PROTOCOL (Version 1) available at Protocol Exchange. 2009. doi: 10.1038/nprot.2009.163.</mixed-citation>
              </ref>
              <ref id="CR14">
                <label>14.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Brouwer</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Cork</surname>
                      <given-names>AJ</given-names>
                    </name>
                    <name>
                      <surname>Ong</surname>
                      <given-names>CY</given-names>
                    </name>
                    <name>
                      <surname>Barnett</surname>
                      <given-names>TC</given-names>
                    </name>
                    <name>
                      <surname>West</surname>
                      <given-names>NP</given-names>
                    </name>
                    <name>
                      <surname>McIver</surname>
                      <given-names>KS</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Endopeptidase PepO regulates the SpeB cysteine protease and is essential for the virulence of invasive M1T1 Streptococcus pyogenes</article-title>
                  <source>J Bacteriol</source>
                  <year>2018</year>
                  <volume>200</volume>
                  <issue>8</issue>
                  <fpage>e00654</fpage>
                  <lpage>e00617</lpage>
                  <pub-id pub-id-type="doi">10.1128/JB.00654-17</pub-id>
                  <pub-id pub-id-type="pmid">29378883</pub-id>
                </element-citation>
              </ref>
              <ref id="CR15">
                <label>15.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Carvalho</surname>
                      <given-names>MGS</given-names>
                    </name>
                    <name>
                      <surname>Tondella</surname>
                      <given-names>ML</given-names>
                    </name>
                    <name>
                      <surname>McCaustland</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Weidlich</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>McGee</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Mayer</surname>
                      <given-names>LW</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Evaluation and improvement of real-time PCR assays targeting lytA, ply, and psaA genes for detection of pneumococcal DNA</article-title>
                  <source>J Clin Microbiol</source>
                  <year>2007</year>
                  <volume>45</volume>
                  <issue>8</issue>
                  <fpage>2460</fpage>
                  <lpage>2466</lpage>
                  <pub-id pub-id-type="doi">10.1128/JCM.02498-06</pub-id>
                  <pub-id pub-id-type="pmid">17537936</pub-id>
                </element-citation>
              </ref>
              <ref id="CR16">
                <label>16.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Diaz</surname>
                      <given-names>MH</given-names>
                    </name>
                    <name>
                      <surname>Waller</surname>
                      <given-names>JL</given-names>
                    </name>
                    <name>
                      <surname>Napoliello</surname>
                      <given-names>RA</given-names>
                    </name>
                    <name>
                      <surname>Islam</surname>
                      <given-names>MS</given-names>
                    </name>
                    <name>
                      <surname>Wolff</surname>
                      <given-names>BJ</given-names>
                    </name>
                    <name>
                      <surname>Burken</surname>
                      <given-names>DJ</given-names>
                    </name>
                    <name>
                      <surname>Holden</surname>
                      <given-names>RL</given-names>
                    </name>
                    <name>
                      <surname>Srinivasan</surname>
                      <given-names>V</given-names>
                    </name>
                    <name>
                      <surname>Arvay</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>McGee</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Oberste</surname>
                      <given-names>MS</given-names>
                    </name>
                    <name>
                      <surname>Whitney</surname>
                      <given-names>CG</given-names>
                    </name>
                    <name>
                      <surname>Schrag</surname>
                      <given-names>SJ</given-names>
                    </name>
                    <name>
                      <surname>Winchell</surname>
                      <given-names>JM</given-names>
                    </name>
                    <name>
                      <surname>Saha</surname>
                      <given-names>SK</given-names>
                    </name>
                  </person-group>
                  <article-title>Optimization of multiple pathogen detection using the TaqMan Array card: application for a population-based study of neonatal infection</article-title>
                  <source>PLoS One</source>
                  <year>2013</year>
                  <volume>8</volume>
                  <issue>6</issue>
                  <fpage>e66183</fpage>
                  <pub-id pub-id-type="doi">10.1371/journal.pone.0066183</pub-id>
                  <?supplied-pmid 23805203?>
                  <pub-id pub-id-type="pmid">23805203</pub-id>
                </element-citation>
              </ref>
              <ref id="CR17">
                <label>17.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Wang</surname>
                      <given-names>X</given-names>
                    </name>
                    <name>
                      <surname>Mair</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Hatcher</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Theodore</surname>
                      <given-names>MJ</given-names>
                    </name>
                    <name>
                      <surname>Edmond</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Wu</surname>
                      <given-names>HM</given-names>
                    </name>
                    <name>
                      <surname>Harcourt</surname>
                      <given-names>BH</given-names>
                    </name>
                    <name>
                      <surname>Carvalho</surname>
                      <given-names>MGS</given-names>
                    </name>
                    <name>
                      <surname>Pimenta</surname>
                      <given-names>F</given-names>
                    </name>
                    <name>
                      <surname>Nymadawa</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Altantsetseg</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Kirsch</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Satola</surname>
                      <given-names>SW</given-names>
                    </name>
                    <name>
                      <surname>Cohn</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Messonnier</surname>
                      <given-names>NE</given-names>
                    </name>
                    <name>
                      <surname>Mayer</surname>
                      <given-names>LW</given-names>
                    </name>
                  </person-group>
                  <article-title>Detection of bacterial pathogens in Mongolia meningitis surveillance with a new real-time PCR assay to detect Haemophilus influenzae</article-title>
                  <source>Int J Med Microbiol</source>
                  <year>2011</year>
                  <volume>301</volume>
                  <issue>4</issue>
                  <fpage>303</fpage>
                  <lpage>309</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.ijmm.2010.11.004</pub-id>
                  <?supplied-pmid 21276750?>
                  <pub-id pub-id-type="pmid">21276750</pub-id>
                </element-citation>
              </ref>
              <ref id="CR18">
                <label>18.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Hii</surname>
                      <given-names>SF</given-names>
                    </name>
                    <name>
                      <surname>Senevirathna</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Llewellyn</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Inpankaew</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Odermatt</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Khieu</surname>
                      <given-names>V</given-names>
                    </name>
                    <name>
                      <surname>Muth</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>McCarthy</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Traub</surname>
                      <given-names>RJ</given-names>
                    </name>
                  </person-group>
                  <article-title>Development and evaluation of a multiplex quantitative Real-Time polymerase chain reaction for hookworm species in human stool</article-title>
                  <source>Am J Trop Med Hyg</source>
                  <year>2018</year>
                  <volume>99</volume>
                  <issue>5</issue>
                  <fpage>1186</fpage>
                  <lpage>1193</lpage>
                  <pub-id pub-id-type="doi">10.4269/ajtmh.18-0276</pub-id>
                  <?supplied-pmid 30226132?>
                  <pub-id pub-id-type="pmid">30226132</pub-id>
                </element-citation>
              </ref>
              <ref id="CR19">
                <label>19.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Sanderson-Smith</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>De Oliveira</surname>
                      <given-names>DM</given-names>
                    </name>
                    <name>
                      <surname>Guglielmini</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>McMillan</surname>
                      <given-names>DJ</given-names>
                    </name>
                    <name>
                      <surname>Vu</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Holien</surname>
                      <given-names>JK</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>A systematic and functional classification of streptococcus pyogenes that serves as a new tool for molecular typing and vaccine development</article-title>
                  <source>J Infect Dis</source>
                  <year>2014</year>
                  <volume>210</volume>
                  <issue>8</issue>
                  <fpage>1325</fpage>
                  <lpage>1338</lpage>
                  <pub-id pub-id-type="doi">10.1093/infdis/jiu260</pub-id>
                  <?supplied-pmid 24799598?>
                  <pub-id pub-id-type="pmid">24799598</pub-id>
                </element-citation>
              </ref>
              <ref id="CR20">
                <label>20.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Berry</surname>
                      <given-names>GJ</given-names>
                    </name>
                    <name>
                      <surname>Miller</surname>
                      <given-names>CR</given-names>
                    </name>
                    <name>
                      <surname>Prats</surname>
                      <given-names>MM</given-names>
                    </name>
                    <name>
                      <surname>Marquez</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Oladipo</surname>
                      <given-names>OO</given-names>
                    </name>
                    <name>
                      <surname>Loeffelholz</surname>
                      <given-names>MJ</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Comparison of the Alere i Strep A Test and the BD veritor system in the detection of group A Streptococcus and the hypothetical impact of results on antibiotic utilization</article-title>
                  <source>J Clin Microbiol</source>
                  <year>2018</year>
                  <volume>56</volume>
                  <issue>3</issue>
                  <fpage>e01310</fpage>
                  <lpage>e01317</lpage>
                  <pub-id pub-id-type="doi">10.1128/JCM.01310-17</pub-id>
                  <pub-id pub-id-type="pmid">29305539</pub-id>
                </element-citation>
              </ref>
              <ref id="CR21">
                <label>21.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Wang</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Zhou</surname>
                      <given-names>N</given-names>
                    </name>
                    <name>
                      <surname>Xu</surname>
                      <given-names>B</given-names>
                    </name>
                    <name>
                      <surname>Hao</surname>
                      <given-names>H</given-names>
                    </name>
                    <name>
                      <surname>Kang</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Zheng</surname>
                      <given-names>Y</given-names>
                    </name>
                    <name>
                      <surname>Jiang</surname>
                      <given-names>Y</given-names>
                    </name>
                    <name>
                      <surname>Jiang</surname>
                      <given-names>H</given-names>
                    </name>
                  </person-group>
                  <article-title>Identification and cluster analysis of streptococcus pyogenes by MALDI-TOF mass spectrometry</article-title>
                  <source>PLoS One</source>
                  <year>2012</year>
                  <volume>7</volume>
                  <issue>11</issue>
                  <fpage>e47152</fpage>
                  <pub-id pub-id-type="doi">10.1371/journal.pone.0047152</pub-id>
                  <?supplied-pmid 23144803?>
                  <pub-id pub-id-type="pmid">23144803</pub-id>
                </element-citation>
              </ref>
              <ref id="CR22">
                <label>22.</label>
                <mixed-citation publication-type="other">CDC. Protocol for <italic>emm</italic> typing June 15, 2018 [Available from: <ext-link ext-link-type="uri" xlink:href="https://www.cdc.gov/streplab/groupa-strep/emm-typing-protocol.html">https://www.cdc.gov/streplab/groupa-strep/emm-typing-protocol.html</ext-link>. Accessed19 March 2020.</mixed-citation>
              </ref>
              <ref id="CR23">
                <label>23.</label>
                <mixed-citation publication-type="other">Agilent T. AriaMx Real-Time PCR Software 2016 [updated February 2016. Available from: <ext-link ext-link-type="uri" xlink:href="https://www.agilent.com/cs/library/usermanuals/Public/AriaMx_SoftwareManual.pdf">https://www.agilent.com/cs/library/usermanuals/Public/AriaMx_SoftwareManual.pdf</ext-link>. Accessed 6 June 2019.</mixed-citation>
              </ref>
              <ref id="CR24">
                <label>24.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Felsenstein</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Faddoul</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Sposto</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Batoon</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Polanco</surname>
                      <given-names>CM</given-names>
                    </name>
                    <name>
                      <surname>Dien</surname>
                      <given-names>BJ</given-names>
                    </name>
                  </person-group>
                  <article-title>Molecular and clinical diagnosis of group a streptococcal pharyngitis in children</article-title>
                  <source>J Clin Microbiol</source>
                  <year>2014</year>
                  <volume>52</volume>
                  <issue>11</issue>
                  <fpage>3884</fpage>
                  <lpage>3889</lpage>
                  <pub-id pub-id-type="doi">10.1128/JCM.01489-14</pub-id>
                  <?supplied-pmid 25143573?>
                  <pub-id pub-id-type="pmid">25143573</pub-id>
                </element-citation>
              </ref>
              <ref id="CR25">
                <label>25.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Homme</surname>
                      <given-names>JH</given-names>
                    </name>
                    <name>
                      <surname>Greenwood</surname>
                      <given-names>CS</given-names>
                    </name>
                    <name>
                      <surname>Cronk</surname>
                      <given-names>LB</given-names>
                    </name>
                    <name>
                      <surname>Nyre</surname>
                      <given-names>LM</given-names>
                    </name>
                    <name>
                      <surname>Uhl</surname>
                      <given-names>JR</given-names>
                    </name>
                    <name>
                      <surname>Weaver</surname>
                      <given-names>AL</given-names>
                    </name>
                    <name>
                      <surname>Patel</surname>
                      <given-names>R</given-names>
                    </name>
                  </person-group>
                  <article-title>Duration of group a streptococcus PCR positivity following antibiotic treatment of pharyngitis</article-title>
                  <source>Diagn Microbiol Infect Dis</source>
                  <year>2018</year>
                  <volume>90</volume>
                  <issue>2</issue>
                  <fpage>105</fpage>
                  <lpage>108</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.diagmicrobio.2017.10.003</pub-id>
                  <?supplied-pmid 29150372?>
                  <pub-id pub-id-type="pmid">29150372</pub-id>
                </element-citation>
              </ref>
              <ref id="CR26">
                <label>26.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kulkarni</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Aikawa</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Nozawa</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Murase</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Maruyama</surname>
                      <given-names>F</given-names>
                    </name>
                    <name>
                      <surname>Nakagawa</surname>
                      <given-names>I</given-names>
                    </name>
                  </person-group>
                  <article-title>DNA-based culture-independent analysis detects the presence of group a streptococcus in throat samples from healthy adults in Japan</article-title>
                  <source>BMC Microbiol</source>
                  <year>2016</year>
                  <volume>16</volume>
                  <issue>1</issue>
                  <fpage>237</fpage>
                  <pub-id pub-id-type="doi">10.1186/s12866-016-0858-5</pub-id>
                  <?supplied-pmid 27724855?>
                  <pub-id pub-id-type="pmid">27724855</pub-id>
                </element-citation>
              </ref>
              <ref id="CR27">
                <label>27.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Rao</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Berg</surname>
                      <given-names>B</given-names>
                    </name>
                    <name>
                      <surname>Quezada</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Fader</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Walker</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Tang</surname>
                      <given-names>S</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Diagnosis and antibiotic treatment of group a streptococcal pharyngitis in children in a primary care setting: impact of point-of-care polymerase chain reaction</article-title>
                  <source>BMC Pediatr</source>
                  <year>2019</year>
                  <volume>19</volume>
                  <issue>1</issue>
                  <fpage>24</fpage>
                  <pub-id pub-id-type="doi">10.1186/s12887-019-1393-y</pub-id>
                  <pub-id pub-id-type="pmid">30651115</pub-id>
                </element-citation>
              </ref>
              <ref id="CR28">
                <label>28.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Chen</surname>
                      <given-names>WH</given-names>
                    </name>
                    <name>
                      <surname>Cohen</surname>
                      <given-names>MB</given-names>
                    </name>
                    <name>
                      <surname>Kirkpatrick</surname>
                      <given-names>BD</given-names>
                    </name>
                    <name>
                      <surname>Brady</surname>
                      <given-names>RC</given-names>
                    </name>
                    <name>
                      <surname>Galloway</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Gurwith</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Hall</surname>
                      <given-names>RH</given-names>
                    </name>
                    <name>
                      <surname>Kessler</surname>
                      <given-names>RA</given-names>
                    </name>
                    <name>
                      <surname>Lock</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Haney</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Lyon</surname>
                      <given-names>CE</given-names>
                    </name>
                    <name>
                      <surname>Pasetti</surname>
                      <given-names>MF</given-names>
                    </name>
                    <name>
                      <surname>Simon</surname>
                      <given-names>JK</given-names>
                    </name>
                    <name>
                      <surname>Szabo</surname>
                      <given-names>F</given-names>
                    </name>
                    <name>
                      <surname>Tennant</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Levine</surname>
                      <given-names>MM</given-names>
                    </name>
                  </person-group>
                  <article-title>Single-dose live Oral cholera vaccine CVD 103-HgR protects against human experimental infection with Vibrio cholerae O1 El tor</article-title>
                  <source>Clin Infect Dis</source>
                  <year>2016</year>
                  <volume>62</volume>
                  <issue>11</issue>
                  <fpage>1329</fpage>
                  <lpage>1335</lpage>
                  <pub-id pub-id-type="doi">10.1093/cid/ciw145</pub-id>
                  <?supplied-pmid 27001804?>
                  <pub-id pub-id-type="pmid">27001804</pub-id>
                </element-citation>
              </ref>
              <ref id="CR29">
                <label>29.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Harro</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Chakraborty</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Feller</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>DeNearing</surname>
                      <given-names>B</given-names>
                    </name>
                    <name>
                      <surname>Cage</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Ram</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Lundgren</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Svennerholm</surname>
                      <given-names>AM</given-names>
                    </name>
                    <name>
                      <surname>Bourgeois</surname>
                      <given-names>AL</given-names>
                    </name>
                    <name>
                      <surname>Walker</surname>
                      <given-names>RI</given-names>
                    </name>
                    <name>
                      <surname>Sack</surname>
                      <given-names>DA</given-names>
                    </name>
                  </person-group>
                  <article-title>Refinement of a human challenge model for evaluation of enterotoxigenic Escherichia coli vaccines</article-title>
                  <source>Clin Vaccine Immunol</source>
                  <year>2011</year>
                  <volume>18</volume>
                  <issue>10</issue>
                  <fpage>1719</fpage>
                  <lpage>1727</lpage>
                  <pub-id pub-id-type="doi">10.1128/CVI.05194-11</pub-id>
                  <?supplied-pmid 21852546?>
                  <pub-id pub-id-type="pmid">21852546</pub-id>
                </element-citation>
              </ref>
              <ref id="CR30">
                <label>30.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Fox</surname>
                      <given-names>EN</given-names>
                    </name>
                    <name>
                      <surname>Waldman</surname>
                      <given-names>RH</given-names>
                    </name>
                    <name>
                      <surname>Wittner</surname>
                      <given-names>MK</given-names>
                    </name>
                    <name>
                      <surname>Mauceri</surname>
                      <given-names>AA</given-names>
                    </name>
                    <name>
                      <surname>Dorfman</surname>
                      <given-names>A</given-names>
                    </name>
                  </person-group>
                  <article-title>Protective study with a group a streptococcal M protein vaccine. Infectivity of human challenge volunteers</article-title>
                  <source>J Clin Invest</source>
                  <year>1973</year>
                  <volume>52</volume>
                  <issue>8</issue>
                  <fpage>1885</fpage>
                  <lpage>1892</lpage>
                  <pub-id pub-id-type="doi">10.1172/JCI107372</pub-id>
                  <?supplied-pmid 4719668?>
                  <pub-id pub-id-type="pmid">4719668</pub-id>
                </element-citation>
              </ref>
              <ref id="CR31">
                <label>31.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Polly</surname>
                      <given-names>SM</given-names>
                    </name>
                    <name>
                      <surname>Waldman</surname>
                      <given-names>RH</given-names>
                    </name>
                    <name>
                      <surname>High</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Wittner</surname>
                      <given-names>MK</given-names>
                    </name>
                    <name>
                      <surname>Dorfman</surname>
                      <given-names>A</given-names>
                    </name>
                  </person-group>
                  <article-title>Protective studies with a group a streptococcal M protein vaccine. II. Challange of volenteers after local immunization in the upper respiratory tract</article-title>
                  <source>J Infect Dis</source>
                  <year>1975</year>
                  <volume>131</volume>
                  <issue>3</issue>
                  <fpage>217</fpage>
                  <lpage>224</lpage>
                  <pub-id pub-id-type="doi">10.1093/infdis/131.3.217</pub-id>
                  <?supplied-pmid 1092765?>
                  <pub-id pub-id-type="pmid">1092765</pub-id>
                </element-citation>
              </ref>
              <ref id="CR32">
                <label>32.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Virtaneva</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Graham</surname>
                      <given-names>MR</given-names>
                    </name>
                    <name>
                      <surname>Porcella</surname>
                      <given-names>SF</given-names>
                    </name>
                    <name>
                      <surname>Hoe</surname>
                      <given-names>NP</given-names>
                    </name>
                    <name>
                      <surname>Su</surname>
                      <given-names>H</given-names>
                    </name>
                    <name>
                      <surname>Graviss</surname>
                      <given-names>EA</given-names>
                    </name>
                    <name>
                      <surname>Gardner</surname>
                      <given-names>TJ</given-names>
                    </name>
                    <name>
                      <surname>Allison</surname>
                      <given-names>JE</given-names>
                    </name>
                    <name>
                      <surname>Lemon</surname>
                      <given-names>WJ</given-names>
                    </name>
                    <name>
                      <surname>Bailey</surname>
                      <given-names>JR</given-names>
                    </name>
                    <name>
                      <surname>Parnell</surname>
                      <given-names>MJ</given-names>
                    </name>
                    <name>
                      <surname>Musser</surname>
                      <given-names>JM</given-names>
                    </name>
                  </person-group>
                  <article-title>Group a streptococcus gene expression in humans and cynomolgus macaques with acute pharyngitis</article-title>
                  <source>Infect Immun</source>
                  <year>2003</year>
                  <volume>71</volume>
                  <issue>4</issue>
                  <fpage>2199</fpage>
                  <lpage>2207</lpage>
                  <pub-id pub-id-type="doi">10.1128/IAI.71.4.2199-2207.2003</pub-id>
                  <?supplied-pmid 12654842?>
                  <pub-id pub-id-type="pmid">12654842</pub-id>
                </element-citation>
              </ref>
              <ref id="CR33">
                <label>33.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Rivera-Hernandez</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Carnathan</surname>
                      <given-names>DG</given-names>
                    </name>
                    <name>
                      <surname>Jones</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Cork</surname>
                      <given-names>AJ</given-names>
                    </name>
                    <name>
                      <surname>Davies</surname>
                      <given-names>MR</given-names>
                    </name>
                    <name>
                      <surname>Moyle</surname>
                      <given-names>PM</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>An experimental group a Streptococcus vaccine that reduces pharyngitis and tonsillitis in a nonhuman primate model</article-title>
                  <source>mBio</source>
                  <year>2019</year>
                  <volume>10</volume>
                  <issue>2</issue>
                  <fpage>e00693</fpage>
                  <lpage>e00619</lpage>
                  <pub-id pub-id-type="doi">10.1128/mBio.00693-19</pub-id>
                  <pub-id pub-id-type="pmid">31040243</pub-id>
                </element-citation>
              </ref>
              <ref id="CR34">
                <label>34.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Skinner</surname>
                      <given-names>JM</given-names>
                    </name>
                    <name>
                      <surname>Caro-Aguilar</surname>
                      <given-names>IC</given-names>
                    </name>
                    <name>
                      <surname>Payne</surname>
                      <given-names>AM</given-names>
                    </name>
                    <name>
                      <surname>Indrawati</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Fontenot</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Heinrichs</surname>
                      <given-names>JH</given-names>
                    </name>
                  </person-group>
                  <article-title>Comparison of rhesus and cynomolgus macaques in a streptococcus pyogenes infection model for vaccine evaluation</article-title>
                  <source>Microb Pathog</source>
                  <year>2011</year>
                  <volume>50</volume>
                  <issue>1</issue>
                  <fpage>39</fpage>
                  <lpage>47</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.micpath.2010.10.004</pub-id>
                  <?supplied-pmid 21035535?>
                  <pub-id pub-id-type="pmid">21035535</pub-id>
                </element-citation>
              </ref>
              <ref id="CR35">
                <label>35.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Zhu</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Olsen</surname>
                      <given-names>RJ</given-names>
                    </name>
                    <name>
                      <surname>Beres</surname>
                      <given-names>SB</given-names>
                    </name>
                    <name>
                      <surname>Saavedra</surname>
                      <given-names>MO</given-names>
                    </name>
                    <name>
                      <surname>Kubiak</surname>
                      <given-names>SL</given-names>
                    </name>
                    <name>
                      <surname>Cantu</surname>
                      <given-names>CC</given-names>
                    </name>
                    <name>
                      <surname>Jenkins</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Waller</surname>
                      <given-names>AS</given-names>
                    </name>
                    <name>
                      <surname>Sun</surname>
                      <given-names>Z</given-names>
                    </name>
                    <name>
                      <surname>Palzkill</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Porter</surname>
                      <given-names>AR</given-names>
                    </name>
                    <name>
                      <surname>DeLeo</surname>
                      <given-names>FR</given-names>
                    </name>
                    <name>
                      <surname>Musser</surname>
                      <given-names>JM</given-names>
                    </name>
                  </person-group>
                  <article-title>Streptococcus pyogenes genes that promote pharyngitis in primates</article-title>
                  <source>JCI Insight</source>
                  <year>2020</year>
                  <volume>5</volume>
                  <issue>11</issue>
                  <fpage>e137686</fpage>
                  <pub-id pub-id-type="doi">10.1172/jci.insight.137686</pub-id>
                </element-citation>
              </ref>
              <ref id="CR36">
                <label>36.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Slinger</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Goldfarb</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Rajakumar</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Moldovan</surname>
                      <given-names>I</given-names>
                    </name>
                    <name>
                      <surname>Barrowman</surname>
                      <given-names>N</given-names>
                    </name>
                    <name>
                      <surname>Tam</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Chan</surname>
                      <given-names>F</given-names>
                    </name>
                  </person-group>
                  <article-title>Rapid PCR detection of group a streptococcus from flocked throat swabs: a retrospective clinical study</article-title>
                  <source>Ann Clin Microbiol Antimicrob</source>
                  <year>2011</year>
                  <volume>10</volume>
                  <issue>1</issue>
                  <fpage>33</fpage>
                  <pub-id pub-id-type="doi">10.1186/1476-0711-10-33</pub-id>
                  <?supplied-pmid 21888649?>
                  <pub-id pub-id-type="pmid">21888649</pub-id>
                </element-citation>
              </ref>
              <ref id="CR37">
                <label>37.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Wu</surname>
                      <given-names>HM</given-names>
                    </name>
                    <name>
                      <surname>Cordeiro</surname>
                      <given-names>SM</given-names>
                    </name>
                    <name>
                      <surname>Harcourt</surname>
                      <given-names>BH</given-names>
                    </name>
                    <name>
                      <surname>Carvalho</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Azevedo</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Oliveira</surname>
                      <given-names>TQ</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Accuracy of real-time PCR, gram stain and culture for Streptococcus pneumoniae, Neisseria meningitidis and Haemophilus influenzae meningitis diagnosis</article-title>
                  <source>BMC Infect Dis</source>
                  <year>2013</year>
                  <volume>13</volume>
                  <fpage>26</fpage>
                  <pub-id pub-id-type="doi">10.1186/1471-2334-13-26</pub-id>
                  <pub-id pub-id-type="pmid">23339355</pub-id>
                </element-citation>
              </ref>
              <ref id="CR38">
                <label>38.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Rockett</surname>
                      <given-names>RJ</given-names>
                    </name>
                    <name>
                      <surname>Tozer</surname>
                      <given-names>SJ</given-names>
                    </name>
                    <name>
                      <surname>Peatey</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Bialasiewicz</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Whiley</surname>
                      <given-names>DM</given-names>
                    </name>
                    <name>
                      <surname>Nissen</surname>
                      <given-names>MD</given-names>
                    </name>
                    <name>
                      <surname>Trenholme</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Mc Carthy</surname>
                      <given-names>JS</given-names>
                    </name>
                    <name>
                      <surname>Sloots</surname>
                      <given-names>TP</given-names>
                    </name>
                  </person-group>
                  <article-title>A real-time, quantitative PCR method using hydrolysis probes for the monitoring of plasmodium falciparum load in experimentally infected human volunteers</article-title>
                  <source>Malar J</source>
                  <year>2011</year>
                  <volume>10</volume>
                  <issue>1</issue>
                  <fpage>48</fpage>
                  <pub-id pub-id-type="doi">10.1186/1475-2875-10-48</pub-id>
                  <?supplied-pmid 21352599?>
                  <pub-id pub-id-type="pmid">21352599</pub-id>
                </element-citation>
              </ref>
              <ref id="CR39">
                <label>39.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Pop</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Paulson</surname>
                      <given-names>JN</given-names>
                    </name>
                    <name>
                      <surname>Chakraborty</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Astrovskaya</surname>
                      <given-names>I</given-names>
                    </name>
                    <name>
                      <surname>Lindsay</surname>
                      <given-names>BR</given-names>
                    </name>
                    <name>
                      <surname>Li</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Bravo</surname>
                      <given-names>HC</given-names>
                    </name>
                    <name>
                      <surname>Harro</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Parkhill</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Walker</surname>
                      <given-names>AW</given-names>
                    </name>
                    <name>
                      <surname>Walker</surname>
                      <given-names>RI</given-names>
                    </name>
                    <name>
                      <surname>Sack</surname>
                      <given-names>DA</given-names>
                    </name>
                    <name>
                      <surname>Stine</surname>
                      <given-names>OC</given-names>
                    </name>
                  </person-group>
                  <article-title>Individual-specific changes in the human gut microbiota after challenge with enterotoxigenic Escherichia coli and subsequent ciprofloxacin treatment</article-title>
                  <source>BMC Genomics</source>
                  <year>2016</year>
                  <volume>17</volume>
                  <issue>1</issue>
                  <fpage>440</fpage>
                  <pub-id pub-id-type="doi">10.1186/s12864-016-2777-0</pub-id>
                  <?supplied-pmid 27277524?>
                  <pub-id pub-id-type="pmid">27277524</pub-id>
                </element-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
